Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2017 Feb 10;18(1):76.
doi: 10.1186/s12891-017-1404-9.

Towards an optimal therapy strategy for myogenous TMD, physiotherapy compared with occlusal splint therapy in an RCT with therapy-and-patient-specific treatment durations

Affiliations
Randomized Controlled Trial

Towards an optimal therapy strategy for myogenous TMD, physiotherapy compared with occlusal splint therapy in an RCT with therapy-and-patient-specific treatment durations

Robert J van Grootel et al. BMC Musculoskelet Disord. .

Abstract

Background: Temporomandibular Disorders (TMD) may be characterized by pain and restricted jaw movements. In the absence of somatic factors in the temporomandibular joint, mainly myogenous, psychobiological, and psychosocial factors may be involved in the aetiology of myogenous TMD. An occlusal appliance (splint) is commonly used as a basic therapy of the dental practice. Alternatively, a type of physiotherapy which includes, apart from massage of sore muscles, aspects of cognitive-behavioural therapy might be a basic therapy for myogenous TMD. Treatment outcome of physiotherapy (Ph-Tx) was evaluated in comparison to that of splint therapy (Sp-Tx), using the index Treatment Duration Control (TDC) that enabled a randomized controlled trial with, comparable to clinical care, therapy-and-patient-specific treatment durations.

Methods: Seventy-two patients were randomly assigned to either Ph-Tx or Sp-Tx, with an intended treatment duration between 10 and 21 or 12 and 30 weeks respectively. Using TDC, the clinician controlled treatment duration and the number of visits needed. A blinded assessor recorded anamnestic and clinical data to determine TDC-values following treatment and a 1-year follow-up, yielding success rate (SR) and effectiveness (mean TDC) as treatment outcomes. Cohen's d, was determined for pain intensity. Overall SR for stepped-care was assessed in a theoretical model, i.e. a second of the two studied therapies was applied if the first treatment was unsuccessful, and the effect of therapy sequence and difference in success rates was examined.

Results: SR and effectiveness were similar for Ph-Tx and Sp-Tx (long-term SR: 51-60%; TDC: -0.512- -0.575). Cohen's d was 0.86 (Ph-Tx) and 1.39 (Sp-Tx). Treatment duration was shorter for Ph-Tx (on average 10.4 weeks less; p < 0.001). Sp-Tx needed 7.1 less visits (p < 0.001).

Conclusions: Physiotherapy may be preferred as initial therapy over occlusal splint therapy in stepped-care of myogenous TMD. With a similar SR and effectiveness, physiotherapy has a shorter duration. Thus patients whose initial physiotherapy is unsuccessful can continue earlier with subsequent treatment. The stepped-care model reinforces the conclusion on therapy preference as the overall SR hardly depends on therapy sequence.

Trial registration: isrctn.com/ISRCTN17469828 . Retrospectively registered: 11/11/2016.

Keywords: Medical decision; Myofascial pain syndrome; Occlusal splint; Physiotherapy; Randomized controlled trial; Stepped-care; Temporomandibular disorders.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Patient flow. Tx, treatment. FU, follow-up evaluation, 6 and 12 months after end of Tx. Dropout patients, patients who did not complete the entire treatment procedure at various stages, for various reasons (see text); STx and UTx patients, patients whose Tx is successful or unsuccessful respectively, according to the TDC procedure, at a particular stage; n-Ph Tx, number of patients assigned to physiotherapy; n-Sp Tx, number of patients assigned to splint therapy
Fig. 2
Fig. 2
Intensity of predominant pain in the masticatory system. This intensity (mm on a 100 mm VAS) is depicted as a function of time for two types of therapy, two treatment outcomes according to TDC (successful treatment, STx; unsuccessful treatment, UTx), and the various pre-treatment and treatment stages. Mean and SEM are depicted for pain intensity as well as the timing of the stages. Stages: I, initial visit; St-Tx, start of treatment (corresponding with the zero point of time); E-Tx, end of treatment; EM, end measurement of treatment at the first post-treatment visit; LM, last measurement from patients with a successful treatment, following a 1-year-follow-up. For statistical testing of the various levels of pain intensity, see Additional file 1: Table S7

References

    1. Okeson JP. Orofacial pain: guidelines for assessment, classification, and management. The American Academy of Orofacial Pain. Illinois: Quintessence; 1996.
    1. Dworkin SF, LeResche L. Research diagnostic criteria for temporomandibular mandibular disorders: review, criteria, examinations and specifications, critique. J Craniomandib Disord. 1992;6:301–355. - PubMed
    1. Diatchenko L, Nackley AG, Slade GD, Fillingim RB, Maixner W. Idiopathic pain disorders – Pathways of vulnerability. Pain. 2006;123:226–230. doi: 10.1016/j.pain.2006.04.015. - DOI - PubMed
    1. Benoliel R, Svensson P, Eliav E. Pathophysiology of masticatory myofascial pain. In: Greene CS, Laskin DM, editors. Treatment of TMDs: bridging the gap between advances in research and clinical patient management. Illinois: Quintessence; 2013. pp. 17–32.
    1. Dubner R, Ren K, Sessle BJ. Sensory mechanisms of orofacial pain. In: Greene CS, Laskin DM, editors. Treatment of TMDs: bridging the gap between advances in research and clinical patient management. Illinois: Quintessence; 2013. pp. 3–16.

Publication types

Associated data